Huangshan Novel (002014) Fundamentals 2026 — P/E 15.3x, Revenue Analysis | SniperIQ
Huangshan Novel (002014) is a CN-listed Consumer Cyclical company in Packaging & Containers with a market capitalization of ¥6.6B, trading at ¥10.83 on the SHZ. This SniperIQ fundamentals page covers Huangshan Novel's valuation (P/E 15.3x, P/B 2.6x), profitability (net margin 11.5%), revenue (¥3.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Huangshan Novel's market cap?
Huangshan Novel (002014) has a market capitalization of approximately ¥6.6B, trading at ¥10.83 on the SHZ. Market cap moves with the live share price.
What is Huangshan Novel's P/E ratio?
Huangshan Novel's trailing twelve-month P/E ratio is 15.3x, with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Consumer Cyclical sector peers rather than read in isolation.
How profitable is Huangshan Novel?
Huangshan Novel runs a net profit margin of 11.5%, a gross margin of 22.9%, and an operating margin of 13.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Huangshan Novel generate?
Huangshan Novel reported revenue of ¥3.7B for fiscal year 2025, with net income of ¥438M and earnings per share (EPS) of 0.72. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Huangshan Novel pay a dividend?
Huangshan Novel offers a trailing dividend yield of about 5.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Huangshan Novel financially healthy?
Huangshan Novel carries a debt-to-equity ratio of 0.35x and a current ratio of 2.17x, with a market beta of 0.26. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Huangshan Novel a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Huangshan Novel (002014) the key facts are: market cap ¥6.6B, P/E 15.3x, revenue ¥3.7B, 52-week range 9.84-12.88. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Cyclical peers and form your own view.
Track Huangshan Novel's full fundamentals live
Get Huangshan Novel's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.